Alprazolam XR

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 59762-0059
  • Package NDC 59762-0059-1
  • Application number NDA021434
  • SPL ID 70f0098e-50b5-4e61-b4e0-141a55d92267
  • SPL set ID 1338d1c9-7c75-42ed-95f3-9eb1b6fc51d3
  • UNII YU55MQ3IZY
  • RxCUI 433798
  • RxCUI 433799
  • RxCUI 433800
  • RxCUI 433801

What the source publishes

Labeler
Mylan Pharmaceuticals Inc.
Active ingredients
alprazolam
Form
TABLET, EXTENDED RELEASE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA AUTHORIZED GENERIC
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:59762-0059_70f0098e-50b5-4e61-b4e0-141a55d92267
{
  "name": "Alprazolam XR",
  "splId": "70f0098e-50b5-4e61-b4e0-141a55d92267",
  "labels": [
    {
      "setId": "1338d1c9-7c75-42ed-95f3-9eb1b6fc51d3",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1338d1c9-7c75-42ed-95f3-9eb1b6fc51d3",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1338d1c9-7c75-42ed-95f3-9eb1b6fc51d3"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Mylan Pharmaceuticals Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (59762-0059-1)",
      "package_ndc": "59762-0059-1",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20030117"
    }
  ],
  "productId": "59762-0059_70f0098e-50b5-4e61-b4e0-141a55d92267",
  "useDomain": "unknown",
  "dosageForm": "TABLET, EXTENDED RELEASE",
  "productNdc": "59762-0059",
  "deaSchedule": "CIV",
  "genericName": "alprazolam",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "ALPRAZOLAM",
      "strength": "1 mg/1"
    }
  ],
  "applicationNumber": "NDA021434",
  "marketingCategory": "NDA AUTHORIZED GENERIC",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20030117",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175694",
      "M0002356"
    ],
    "unii": [
      "YU55MQ3IZY"
    ],
    "rxcui": [
      "433798",
      "433799",
      "433800",
      "433801"
    ],
    "spl_set_id": [
      "1338d1c9-7c75-42ed-95f3-9eb1b6fc51d3"
    ],
    "pharm_class_cs": [
      "Benzodiazepines [CS]"
    ],
    "pharm_class_epc": [
      "Benzodiazepine [EPC]"
    ],
    "manufacturer_name": [
      "Mylan Pharmaceuticals Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:59762-0059_70f0098e-50b5-4e61-b4e0-141a55d92267"